IPI1/NIVO3 Clinical Trials

1 actively recruiting trial

No change since May 2026

Also known as: Ipilimumab 1 mg/kg, Nivolumab 3 mg/kg

Pipeline

Phase 3: 1

Top Sponsors

Vastra Gotaland Region1

Indications

Liver Disease1
Liver Metastases1
Uveal Melanoma1
Liver Cancer1
Cancer1

Other1 trial

PHP in Combination With IPI1/NIVO3 Compared to IPI3/NIVO1 Only in Patients With Uveal Melanoma Liver Metastases

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.